Acquired anticoagulants of immunologic origin: association of circumscribed pemphigoid and an anti-factor VIII anticoagulant
Amblard, P.; Reymond, J.L.; Beani, J.C.; Pouzol, P.; Carpentier, P.
La Nouvelle Presse Medicale 10(31): 2584-2585
1981
ISSN/ISBN: 0301-1518 PMID: 6792592 Document Number: 179850
Document emailed within 1 workday
Related Documents
Taillan, B.; Ferrari, E.; Fuzibet, J.G.; Vinti, H.; Gratecos, N.; Dujardin, P. 1991: Acquired anti-factor V circulating anticoagulant and immunologic diseases Revuedu Rhumatisme et des Maladies Osteo-Articulaires 58(3): 232Kessler, C.M.; Ludlam, C.A. 1993: The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group Seminars in Hematology 30(2 Suppl. 1): 22-27
Teitel, J.M.; Lau, H.K.; Garvey, M.B. 2002: Discrepancies in measured factor VIIi activity in patients treated with factor VIIi concentrate of human or porcine origin Thrombosis and Haemostasis 88(1): 159-160
Mahasandana, C.; Suvatte, V.; Püng-amritt, P.; Tuchinda, S. 1979: Von Willebrand's disease: studies of platelet functions, factor VIII procoagulant activity (F VIII C) and factor VIII-related antigen (F VIII RAg) in three families Southeast Asian Journal of Tropical Medicine and Public Health 10(2): 243-247
Brown, J.E.; Carton, C.L.; Hougie, C. 1981: The effect of naturally occurring antibodies to factor VIIi on an immunoradiometric assay for factor VIIi coagulant antigen. Observation on a cross-reacting material-positive (CRM+) hemophiliac with a factor VIIi inhibit Journal of Laboratory and Clinical Medicine 97(1): 65-71
Okamoto, K.; Tamura, T.; Yamaguchi, K. 2011: Clinical trials of anticoagulants and anticoagulant factor concentrates for the management of DIC in Japan Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 147: 95-103
Takahashi, I.; Furuta, M.; Mizuno, S.; Takamatsu, J.; Kamiya, T. 1993: Effect of substrate and diluent for factor VIIi activity in highly purified factor VIIi concentrate and patient plasma infused factor VIIi concentrate Rinsho Byori. Japanese Journal of Clinical Pathology 41(7): 825-830
Muntean, W. 1984: Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma Wiener Klinische Wochenschrift 96(22): 829-832
Guermazi, S.; Gorgi, Y.; Ayed, K.; Dellagi, K. 1997: Interference of factor VIIi excess on the detection of lupus anticoagulants by the activated partial thromboplastin time Pathologie-Biologie 45(1): 28-33
Tran, T.H.; Duckert, F. 1983: Dissociation of factor VIIi procoagulant antigen VIII:CAg and factor VIIi related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag Thrombosis and Haemostasis 50(2): 547-551
Piedras, J.; Sánchez-Montero, P.E.; Herrera, F.M.; Córdova, M.S.; Sánchez-Medal, L. 1993: Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate Archives of Medical Research 24(1): 23-26
Khammassi, N.; Mohsen, D.; Abdelhedi, H.; Cherif, O. 2013: Acquired combined deficiency of Factor V and VIIi La Tunisie Medicale 91(4): 291-292
Sultan, Y.; Kazatchkine, M.D.; Maisonneuve, P.; Nydegger, U.E. 1984: Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin Lancet 2(8406): 765-768
Green, D. 1994: Immunosuppression of patients with acquired factor VIIi inhibitors Seminars in Hematology 31(2 Suppl 4: 60-61
Petrovic, M.; Derom, E.; Baele, G. 2000: Cyclosporine treatment of acquired hemophilia due to factor VIIi antibodies Haematologica 85(8): 895-896
Genova, V.; Baleva, M.; Nikolov, K. 1987: Factor VIIi (von Willebrand antigen) in patients with acquired thrombocytopathies Vutreshni Bolesti 26(2): 82-85
Merlini, M.; Moccia, F.; Delucchi, M.; Grillo, G. 2005: Severe bleeding in a case of acquired factor VIIi inhibitor associated with generalized pustular psoriasis Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 20(4): 248-252
Brettler, D.B.; Forsberg, A.D.; Levine, P.H.; Aledort, L.M.; Hilgartner, M.W.; Kasper, C.K.; Lusher, J.M.; McMillan, C.; Roberts, H. 1989: The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience Archives of Internal Medicine 149(6): 1381-1385
Liebe, S. 1982: Activation of the antihemophilic globulin a (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIIi Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(4): 110-116
Allersma, D.P.; Smid, W.M.; van der Does, J.A.; van der Meer, J.; Briët, E. 1996: Effects of chronic factor VIII substitution on immune parameters in HIV seronegative haemophiliacs: a comparison between cryoprecipitate and factor VIII concentrate Thrombosis and Haemostasis 75(2): 261-266